Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine local infiltration for postoperative analgesia in elderly lumbar surgery
ChiCTR2500097097Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Feb 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in Lumbar Spinal Disease (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Postoperative pain. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
Lumbar Spinal Disease
Beyond the preview
Go deeper on ChiCTR2500097097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097097.